Platelet-rich plasma market remains influenced by its integral use in the healthcare industry, especially in orthopedic surgeries and cosmetic surgeries. Injuries like rotator cuff, tendon injuries, tennis elbow and hamstring among others are healed quickly and effectively with the help of platelet-rich plasma therapy.
Get | Download Free Sample Copy @ https://www.factmr.com/connectus/sample?flag=S&rep_id=170
Besides, a number of sports injuries are also healed by using platelet-rich plasma therapy. Treatment of medical conditions such as erectile dysfunction and facelift surgeries are some of new application areas in the platelet-rich plasma market. Platelet-rich plasma is a product derived from blood plasma, consisting of enriched platelets, along with several other growth factors, that assist the quick healing of bone and other soft tissues. Due to the several application areas where platelet-rich plasma therapy can be used, especially in cosmetic surgeries, growth of the platelet-rich plasma market has remained significant. However, the high cost of the medical devices associated with platelet-rich plasma therapy may act as a restraint to the growth of the platelet rich plasma market.
Platelet-rich plasma is a type of blood plasma product in which the concentration of platelets is much higher, more than four to eight times higher than the normal concentration of blood platelets. Platelet-rich plasma is also known as platelet enriched plasma, platelet-rich gel and platelet enriched gels. It is used in the quick and effective treatment of many medical conditions such as orthopedic diseases, neurological diseases, sports injuries and cardiothoracic diseases. Additionally, platelet-rich plasma has vast applications in the field of cosmetic surgery.
This Fact.MR report on the global platelet-rich plasma market forecasts that the global platelet-rich plasma market will touch a value of nearly US$ 391 Mn in the year 2022 and grow at a robust CAGR during the assessment period, 2017-2022.
View Full Report@:- https://www.factmr.com/report/170/platelet-rich-plasma-market
North America Set to Dominate Global Platelet-rich Plasma Market
North America is set to lead the global platelet-rich plasma market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America’s platelet-rich plasma market is expected to remain the most attractive, growing at a robust CAGR through 2022.
PRP Therapy Instruments Poised to Touch Nearly US$ 86 Mn Value by 2022-end
As per the forecast of Fact.MR, the instruments segment is expected to reach a value of nearly US$ 86 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Instruments segment is expected to account for more than one-fourth of the revenue share of the global platelet-rich plasma market by the year 2017, but, is also expected to lose market share by the end of the year 2022.
Hospitals – Key End-users of Platelet-rich Plasma
As per the forecast of Fact.MR, the hospitals end user segment is slated to touch a figure of nearly US$ 184 Mn in the year 2022. This represents a CAGR of 10.0% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospitals end user segment accounted for nearly half of the revenue share of the platelet-rich plasma market in 2017.
Request for the Customization of the report: https://www.factmr.com/connectus/sample?flag=RC&rep_id=170
Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of global platelet-rich plasma market through 2022, which include Arthrex, Inc., Johnson & Johnson, Zimmer Biomet Holdings, Inc., Exactech, Inc., Stryker Corporation, Terumo Medical Corporation, Biotest Aktiengesellschaft and CSL Limited.
About Us
We are an insights-driven global market intelligence company with a unique purpose: enabling organizations make better decisions. We do this by creating an ecosystem where an eclectic cognitive collaboration between human imagination and data science leads to path breaking ideas.
Our vision is to foster a pervasive culture where critical business decisions are taken on the basis of facts rather than assumptions and perceptions.
Our mission is empowerment – empowerment of free-thought; empowerment of fact-based decisions; empowerment of decisive action.
For More Information Kindly Contact:
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Mail: sales@factmr.com
Read Blog: https://theheraldmedia.com/
Get | Download Free Sample Copy @ https://www.factmr.com/connectus/sample?flag=S&rep_id=170
Besides, a number of sports injuries are also healed by using platelet-rich plasma therapy. Treatment of medical conditions such as erectile dysfunction and facelift surgeries are some of new application areas in the platelet-rich plasma market. Platelet-rich plasma is a product derived from blood plasma, consisting of enriched platelets, along with several other growth factors, that assist the quick healing of bone and other soft tissues. Due to the several application areas where platelet-rich plasma therapy can be used, especially in cosmetic surgeries, growth of the platelet-rich plasma market has remained significant. However, the high cost of the medical devices associated with platelet-rich plasma therapy may act as a restraint to the growth of the platelet rich plasma market.
Platelet-rich plasma is a type of blood plasma product in which the concentration of platelets is much higher, more than four to eight times higher than the normal concentration of blood platelets. Platelet-rich plasma is also known as platelet enriched plasma, platelet-rich gel and platelet enriched gels. It is used in the quick and effective treatment of many medical conditions such as orthopedic diseases, neurological diseases, sports injuries and cardiothoracic diseases. Additionally, platelet-rich plasma has vast applications in the field of cosmetic surgery.
This Fact.MR report on the global platelet-rich plasma market forecasts that the global platelet-rich plasma market will touch a value of nearly US$ 391 Mn in the year 2022 and grow at a robust CAGR during the assessment period, 2017-2022.
View Full Report@:- https://www.factmr.com/report/170/platelet-rich-plasma-market
North America Set to Dominate Global Platelet-rich Plasma Market
North America is set to lead the global platelet-rich plasma market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America’s platelet-rich plasma market is expected to remain the most attractive, growing at a robust CAGR through 2022.
PRP Therapy Instruments Poised to Touch Nearly US$ 86 Mn Value by 2022-end
As per the forecast of Fact.MR, the instruments segment is expected to reach a value of nearly US$ 86 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Instruments segment is expected to account for more than one-fourth of the revenue share of the global platelet-rich plasma market by the year 2017, but, is also expected to lose market share by the end of the year 2022.
Hospitals – Key End-users of Platelet-rich Plasma
As per the forecast of Fact.MR, the hospitals end user segment is slated to touch a figure of nearly US$ 184 Mn in the year 2022. This represents a CAGR of 10.0% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospitals end user segment accounted for nearly half of the revenue share of the platelet-rich plasma market in 2017.
Request for the Customization of the report: https://www.factmr.com/connectus/sample?flag=RC&rep_id=170
Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of global platelet-rich plasma market through 2022, which include Arthrex, Inc., Johnson & Johnson, Zimmer Biomet Holdings, Inc., Exactech, Inc., Stryker Corporation, Terumo Medical Corporation, Biotest Aktiengesellschaft and CSL Limited.
About Us
We are an insights-driven global market intelligence company with a unique purpose: enabling organizations make better decisions. We do this by creating an ecosystem where an eclectic cognitive collaboration between human imagination and data science leads to path breaking ideas.
Our vision is to foster a pervasive culture where critical business decisions are taken on the basis of facts rather than assumptions and perceptions.
Our mission is empowerment – empowerment of free-thought; empowerment of fact-based decisions; empowerment of decisive action.
For More Information Kindly Contact:
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Mail: sales@factmr.com
Read Blog: https://theheraldmedia.com/
No comments:
Post a Comment